Rosemary A Thornton is a prominent inventor based in Warren, NJ (US). She has made significant contributions to the field of biochemistry, particularly in the study of sphingosine-1-phosphate phosphatases. With a total of 6 patents to her name, her work has advanced our understanding of these important enzymes.

Latest Patents

Among her latest patents is the invention related to human sphingosine-1-phosphate phosphatase and inhibition methods. This invention provides polynucleotides and polypeptides of a human sphingosine-1-phosphate phosphatase, referred to as hSPP1. The polynucleotides and polypeptides are utilized to create expression vectors, host cells, probes, primers, and antibodies against the hSPP1 protein. Additionally, it includes assays for the presence or expression of hSPP1 and for identifying compounds that interact with hSPP1. Another notable patent involves polynucleotide sequences encoding mouse sphingosine-1-phosphate phosphatase, known as mSPP1. Similar to her work on hSPP1, this invention provides essential tools for research and development in the field.

Career Highlights

Rosemary A Thornton is currently associated with Merck & Company, Inc., where she continues to contribute to innovative research. Her work has been instrumental in advancing therapeutic approaches related to sphingosine-1-phosphate phosphatases.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Suzanne M Mandala and Robert A Giacobbe. These collaborations have further enriched her research and expanded the impact of her inventions.

Conclusion

Rosemary A Thornton's contributions to the field of biochemistry through her patents and collaborations highlight her role as a leading inventor. Her work continues to influence research and development in important therapeutic areas.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com